Blood viscosity changes in slow coronary flow patients

被引:47
作者
Ergun-Cagli, Kumral [1 ]
Ileri-Gurel, Esin [2 ]
Ozeke, Ozcan [3 ]
Seringec, Nurten [2 ]
Yalcinkaya, Adnan [4 ]
Kocabeyoglu, Sabit [4 ]
Basar, Fatma Nurcan [1 ]
Sen, Nihat [1 ]
Cagli, Kerim [4 ]
Dikmenoglu, Neslihan [2 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Cardiol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Physiol, TR-06100 Ankara, Turkey
[3] Special Akay Hosp, Ankara, Turkey
[4] Turkiye Yuksek Ihtisas Hosp, Dept Cardiovasc Surg, Ankara, Turkey
关键词
Slow coronary flow; erythrocyte aggregation; plasma viscosity; erythrocyte deformability; CELL ANALYZER LORCA; ERYTHROCYTE AGGREGATION; ANGINA-PECTORIS; ARTERY FLOW; HEMORHEOLOGY; EXPRESSION; PARAMETERS; RESISTANCE; RHEOLOGY; THERAPY;
D O I
10.3233/CH-2010-1362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microvascular dysfunction is implicated in the pathogenesis of slow coronary flow (SCF), but less attention has been paid to intrinsic properties of blood that can also impair the microcirculatory flow. In this study we aimed to evaluate the blood viscosity focusing on erythrocyte aggregation, erythrocyte deformability and plasma viscosity in SCF. Thirty-three patients with SCF (21 male, 54 +/- 12.8 years) and 23 subjects with normal coronary arteries (13 male, 59 +/- 10.3 years) were included in the study. Coronary flow was quantified by means of thrombolysis in myocardial infarction (TIMI) frame count and aggregation and deformability of erythrocytes were measured by an ektacytometer. Plasma viscosity was measured by a cone-plate viscometer. Aggregation amplitude (23 +/- 3.8 au vs. 15.7 +/- 6.1 au, respectively, p < 0.001) and area A index (area above syllectogram) (153.2 +/- 30.7 au.s vs. 124.9 +/- 49.3 au.s, respectively, p < 0.01) were higher in SCF patients. Aggregation half-time, aggregation index, elongation index and plasma viscosity values were similar between two groups. Correlation analysis revealed a significant relationship between the TIMI frame count for left anterior descending artery and aggregation amplitude in SCF patients (r = 0.679, p < 0.0001). The result of this study reveals changes in erythrocyte aggregation which may contribute to the pathophysiology of SCF. Larger studies are needed to make more robust conclusions on this issue.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 40 条
[1]   Efficacy of Nebivolol on Flow-Mediated Dilation in Patients With Slow Coronary Flow [J].
Albayrak, Sinan ;
Ordu, Serkan ;
Yuksel, Hatice ;
Ozhan, Hakan ;
Yazgan, Oemer ;
Yazici, Mehmet .
INTERNATIONAL HEART JOURNAL, 2009, 50 (05) :545-553
[2]  
Barshtein Gregory, 2007, Expert Rev Cardiovasc Ther, V5, P743, DOI 10.1586/14779072.5.4.743
[3]   New guidelines for hemorheological laboratory techniques [J].
Baskurt, Oguz K. ;
Boynard, Michel ;
Cokelet, Giles C. ;
Connes, Philippe ;
Cooke, Brian M. ;
Forconi, Sandro ;
Liao, Fulong ;
Hardeman, Max R. ;
Jung, Friedrich ;
Meiselman, Herbert J. ;
Nash, Gerard ;
Nemeth, Norbert ;
Neu, Bjoern ;
Sandhagen, Bo ;
Shin, Sehyun ;
Thurston, George ;
Wautier, Jean Luc .
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2009, 42 (02) :75-97
[4]  
Baskurt OK, 2004, CLIN HEMORHEOL MICRO, V30, P169
[5]  
Baskurt OK, 2004, CLIN HEMORHEOL MICRO, V31, P23
[6]   Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation [J].
Baskurt, OK ;
Yalcin, O ;
Ozdem, S ;
Armstrong, JK ;
Meiselman, HJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (01) :H222-H229
[7]  
Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435
[8]   The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon [J].
Beltrame, JF ;
Turner, SP ;
Leslie, SL ;
Solomon, P ;
Stats, DM ;
Freedman, SB ;
Horowitz, JD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (01) :57-62
[9]   Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon [J].
Beltrame, JF ;
Limaye, SB ;
Wuttke, RD ;
Horowitz, JD .
AMERICAN HEART JOURNAL, 2003, 146 (01) :84-90
[10]   Gender differences in the expression of erythrocyte aggregation in relation to Bβ-fibrinogen gene polymorphisms in apparently healthy individuals [J].
Ben Assayag, E ;
Bova, I ;
Berliner, S ;
Peretz, H ;
Usher, S ;
Shapira, I ;
Bornstein, NM .
THROMBOSIS AND HAEMOSTASIS, 2006, 95 (03) :428-433